Dagmar Dolby Sells 100,000 Shares of Dolby Laboratories, Inc. (DLB) Stock

Dolby Laboratories, Inc. (NYSE:DLB) major shareholder Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock in a transaction on Thursday, May 24th. The stock was sold at an average price of $61.50, for a total value of $6,150,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Tuesday, May 22nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.31, for a total value of $6,231,000.00.
  • On Friday, May 18th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.49, for a total value of $6,249,000.00.
  • On Wednesday, May 16th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.82, for a total value of $6,282,000.00.
  • On Monday, May 14th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.65, for a total value of $6,265,000.00.
  • On Thursday, May 10th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.23, for a total value of $6,223,000.00.
  • On Tuesday, May 8th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $61.78, for a total value of $6,178,000.00.
  • On Friday, May 4th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $61.03, for a total value of $6,103,000.00.
  • On Wednesday, May 2nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $60.81, for a total value of $6,081,000.00.
  • On Friday, April 27th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $60.39, for a total value of $3,019,500.00.
  • On Monday, April 30th, Dagmar Dolby sold 88,538 shares of Dolby Laboratories stock. The stock was sold at an average price of $60.28, for a total value of $5,337,070.64.

Shares of Dolby Laboratories opened at $61.44 on Friday, MarketBeat Ratings reports. Dolby Laboratories, Inc. has a 1-year low of $48.00 and a 1-year high of $74.29. The firm has a market cap of $6.41 billion, a PE ratio of 27.93, a price-to-earnings-growth ratio of 2.22 and a beta of 0.76.



Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Tuesday, April 24th. The electronics maker reported $0.78 earnings per share for the quarter, beating analysts’ consensus estimates of $0.64 by $0.14. Dolby Laboratories had a return on equity of 12.73% and a net margin of 7.64%. The business had revenue of $301.36 million for the quarter, compared to the consensus estimate of $300.37 million. During the same quarter in the previous year, the company posted $0.63 earnings per share. Dolby Laboratories’s revenue for the quarter was up 12.7% compared to the same quarter last year. analysts expect that Dolby Laboratories, Inc. will post 2.31 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 16th. Stockholders of record on Monday, May 7th were issued a dividend of $0.16 per share. The ex-dividend date was Friday, May 4th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.04%. Dolby Laboratories’s dividend payout ratio is 29.09%.

Hedge funds have recently modified their holdings of the company. Elkfork Partners LLC purchased a new position in shares of Dolby Laboratories during the fourth quarter valued at $102,000. Captrust Financial Advisors purchased a new position in Dolby Laboratories in the fourth quarter valued at about $122,000. Cornerstone Capital Management Holdings LLC. purchased a new position in Dolby Laboratories in the fourth quarter valued at about $145,000. Meadow Creek Investment Management LLC purchased a new position in Dolby Laboratories in the fourth quarter valued at about $179,000. Finally, State of Alaska Department of Revenue purchased a new position in Dolby Laboratories in the fourth quarter valued at about $198,000. Institutional investors and hedge funds own 53.73% of the company’s stock.

DLB has been the topic of a number of recent research reports. Zacks Investment Research cut Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Friday, April 27th. ValuEngine upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Finally, Barrington Research reiterated a “buy” rating and set a $78.00 price target on shares of Dolby Laboratories in a report on Tuesday, May 1st. One research analyst has rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company’s stock. Dolby Laboratories presently has a consensus rating of “Hold” and a consensus price target of $66.50.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply